Tag: NYSE:ACT

Finance

Morning Watch List : Actavis plc (NYSE:ACT), Google Inc (NASDAQ:GOOGL), Rouse Properties, Inc. (NYSE:RSE), DCP Midstream Partners LP (NYSE:DPM), Titan Machinery (NASDAQ:TITN)

Actavis plc (NYSE:ACT) confirmed Thursday that it has filed an Abbreviated New Drug Application or ANDA with the U.S. Food and Drug Administration or FDA seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is 0.60% and weekly performance is -8.34%. On last trading day company shares ended up $222.07. Actavis … Continue reading Morning Watch List : Actavis plc (NYSE:ACT), Google Inc (NASDAQ:GOOGL), Rouse Properties, Inc. (NYSE:RSE), DCP Midstream Partners LP (NYSE:DPM), Titan Machinery (NASDAQ:TITN)

Colin Pettis
Finance

Morning Alert : Actavis (NYSE:ACT), Borderfree (NASDAQ:BRDR), Sohu.com (NASDAQ:SOHU), Rowan Companies (NYSE:RDC), Platform Specialty Products (NYSE:PAH)

Actavis plc’s (NYSE:ACT) new drug application (NDA) for its antibiotic candidate, ceftazidime-avibactam, has been accepted for review by the FDA. Actavis is looking to get ceftazidime-avibactam approved for the treatment of patients with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), including those caused by multi-drug resistant gram-negative bacterial pathogens. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is 0.60% … Continue reading Morning Alert : Actavis (NYSE:ACT), Borderfree (NASDAQ:BRDR), Sohu.com (NASDAQ:SOHU), Rowan Companies (NYSE:RDC), Platform Specialty Products (NYSE:PAH)

Ryan Holtz
Finance

Drugs Generic: Mylan Inc (NASDAQ:MYL), Zoetis Inc (NYSE:ZTS), Actavis plc (NYSE:ACT), Mallinckrodt PLC (NYSE:MNK)

Trade-Ideas LLC identified Mylan Inc (NASDAQ:MYL) as an unusual social activity candidate. MYL has more that 20x the normal benchmarked social activity for this time of the day compared to its average of 2.07 mentions/day. Mylan Inc (NASDAQ:MYL) stock performance was 1.17% in last session and finished the day at $52.63. Traded volume was 7.39million shares in the last session and the average volume of … Continue reading Drugs Generic: Mylan Inc (NASDAQ:MYL), Zoetis Inc (NYSE:ZTS), Actavis plc (NYSE:ACT), Mallinckrodt PLC (NYSE:MNK)

Jason Knox